MK-2866 vs Tadalafil for performance
Short answer: For performance, more users report improvement with Tadalafil — 97% of 61 reports, versus 88% of 192 for MK-2866.
MK-2866 has 0 meta-analyses and 0 randomized trials on PubMed; Tadalafil has 120 and 347.
Based on 612 reports about MK-2866 and 214 about Tadalafil. Not medical advice.
| MK-2866 SARM | Tadalafil Medication | |
|---|---|---|
| User score | 33 | 65 |
| Verdict | Mixed | Mostly positive |
| Positive of reports that state an outcome | 39% | 78% |
| Reports | 612 | 214 |
| Research | DResearch: None | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 0 | 120 / 347 |
| Mainly used for | ||
| Weight loss % reporting improvement | 89% (80) | — |
| Appetite % reporting improvement | 62% (8) | — |
| Focus % reporting improvement | 71% (7) | 88% (8) |
| Energy % reporting improvement | 54% (37) | 100% (6) |
| Sleep % reporting improvement | 20% (20) | 100% (4) |
| Anxiety % reporting improvement | 33% (9) | 75% (4) |
| Mood % reporting improvement | 63% (49) | 100% (9) |
| Performance % reporting improvement | 88% (192) | 97% (61) |
| Recovery % reporting improvement | 97% (60) | 100% (6) |
| Pain & inflammation % reporting improvement | 70% (27) | 100% (2) |
| Libido % reporting improvement | 31% (45) | 91% (82) |
| Hormones % reporting improvement | 4% (82) | 100% (3) |
| Blood sugar % reporting improvement | — | 100% (2) |
| Heart & lipids % reporting improvement | 0% (8) | 100% (17) |
| Skin & hair % reporting improvement | 33% (6) | — |
| Longevity % reporting improvement | — | 100% (2) |
| Common side effects | suppression, fatigue, insomnia, headache | headache, stuffy nose, heartburn, lower back |
| Typical dose reported | Not listed | 2.5-5 mg / daily or 5-10 mg every other day |
MK-2866Full MK-2866 profile →
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
TadalafilFull Tadalafil profile →
Latest review conclusion
Tadalafil shares a similar efficacy and safety with sildenafil and significantly improves patients' sexual confidence. Furthermore, patients and their partners prefer tadalafil to sildenafil. Hence, tadalafil may be a better choice for ED treatment.
Int Urol Nephrol, 2017 ↗What a user said
“After a week of 2.5 mg twice a day, this is my favourite drug ever. My brain fog has gone...My mood is so much better, similar to an SSRI but without the flat feeling.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate